Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$96.41 - $126.61 $153,002 - $200,930
1,587 Added 27.03%
7,458 $770,000
Q2 2023

Jul 10, 2023

BUY
$118.5 - $160.53 $320,424 - $434,073
2,704 Added 85.38%
5,871 $713,000
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $1,627 - $2,364
-12 Reduced 0.38%
3,167 $486,000
Q4 2022

Jan 30, 2023

BUY
$118.38 - $210.04 $376,330 - $667,717
3,179 New
3,179 $571,000
Q4 2021

Feb 02, 2022

SELL
$225.82 - $368.51 $572,002 - $933,435
-2,533 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $404,967 - $884,157
1,825 Added 257.77%
2,533 $620,000
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $91,976 - $166,365
708 New
708 $323,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Castle Rock Wealth Management, LLC Portfolio

Follow Castle Rock Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.